SCHEMBL4190733

SCHEMBL4190733

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc(-n2ccnn2)cc1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
PKM P14618 1/20 0.45
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
CCR1 P32246 4/20 0.39
CCR2 P41597 4/20 0.39
MAPT P10636 5/20 0.39
ALDH1A1 P00352 5/20 0.39
LMNA P02545 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 3/20 0.38
CCR4 P51679 3/20 0.38
RECQL P46063 1/20 0.36
MALT1 Q9UDY8 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 2/20 0.35
GAA P10253 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197688 1.00 KDM4E (0.45) KDM4EPKMMEN1KMT2ACCR1
SCHEMBL4203606 0.89 KMT2A (0.54) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL4189861 0.89 KMT2A (0.53) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL4184025 0.88 KDM4E (0.39) KDM4EPKMCCR1CCR2MAPT
SCHEMBL4201552 0.87 KDM4E (0.40) KDM4EPKMCCR1CCR2MAPT
SCHEMBL4201917 0.86 PKM (0.48) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL4202288 0.85 PKM (0.50) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL4189940 0.85 KDM4E (0.44) KDM4EPKMMEN1KMT2ACCR1
SCHEMBL4196860 0.85 KDM4E (0.44) KDM4EPKMMEN1KMT2AMAPT
SCHEMBL4193489 0.84 KDM4E (0.46) KDM4EPKMMEN1KMT2ACCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 KDM4E 3328/4885PKM 1855/4885MEN1 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.